News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
822,841 Results
Type
Article (85153)
Company Profile (621)
Press Release (737067)
Section
Business (231580)
Career Advice (4090)
Deals (39618)
Drug Delivery (106)
Drug Development (90355)
Employer Resources (192)
FDA (17841)
Job Trends (17242)
News (394159)
Policy (39559)
Tag
Academia (2970)
Africa (1260)
Alliances (56285)
Alzheimer's disease (1237)
Approvals (17770)
Arizona (200)
Artificial intelligence (72)
Asia (48915)
Australia (8609)
Bankruptcy (392)
Best Places to Work (12216)
Biosimilars (71)
Biotechnology (438)
C2C Services and Suppliers (95111)
California (1762)
Canada (815)
Cancer (469)
Career advice (3497)
Cell therapy (138)
China (132)
Clinical research (70316)
Collaboration (132)
Compensation (71)
Connecticut (65)
COVID-19 (2743)
Cystic fibrosis (76)
Data (269)
Diabetes (67)
Diagnostics (6468)
Drug pricing (65)
Earnings (93180)
Employer resources (162)
Europe (111831)
Events (124695)
Executive appointments (133)
FDA (17997)
Florida (204)
Funding (133)
Gene therapy (103)
GLP-1 (584)
Government (4993)
Healthcare (20591)
Hotbed/Location (534575)
Illinois (279)
Indiana (142)
Infectious disease (2763)
Inflammatory bowel disease (101)
Interviews (805)
IPO (17456)
Job creations (5172)
Job search strategy (2849)
Kansas (100)
Layoffs (463)
Legal (9999)
Lung cancer (108)
Manufacturing (87)
Maryland (406)
Massachusetts (1569)
Medical device (14189)
Medtech (14194)
Mergers & acquisitions (21922)
Metabolic disorders (245)
Michigan (118)
Minnesota (207)
Neuroscience (1386)
New Jersey (542)
New York (542)
NextGen Class of 2024 (7621)
Non-profit (5043)
North Carolina (669)
Northern California (737)
Obesity (141)
Ohio (94)
Opinion (234)
Patents (70)
Pennsylvania (510)
People (63626)
Pharmaceutical (118)
Phase I (21608)
Phase II (30534)
Phase III (23066)
Pipeline (94)
Podcasts (76)
Postmarket research (3529)
Preclinical (9761)
Press Release (72)
Rare diseases (130)
Real estate (7358)
Recruiting (72)
Regulatory (25516)
Research institute (2631)
Resumes & cover letters (645)
South America (1641)
Southern California (697)
Startups (4269)
Texas (203)
United States (8220)
Vaccines (548)
Washington State (262)
Weight loss (141)
Date
Today (109)
Last 7 days (541)
Last 30 days (1887)
Last 365 days (38325)
2024 (26503)
2023 (42566)
2022 (53929)
2021 (58727)
2020 (57671)
2019 (51341)
2018 (39126)
2017 (37193)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36269)
2012 (38416)
2011 (38383)
2010 (39616)
822,841 Results for "iveric bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Astellas Completes Acquisition of Iveric Bio
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced that it has successfully completed the acquisition of IVERIC bio, Inc. (NASDAQ: ISEE, CEO: Glenn P. Sblendorio, “Iveric Bio”) with respect to the announcement on April 30, 2023, through its indirect wholly-owned subsidiary Berry Merger Sub, Inc. (the “Acquisition”).
July 11, 2023
·
8 min read
Deals
Astellas Enters into Definitive Agreement to Acquire Iveric Bio
Astellas Pharma Inc. and Iveric bio, Inc. announced that on April 29, 2023, the Companies have entered into a definitive agreement under which Astellas through Berry Merger Sub, Inc., a wholly-owned subsidiary of Astellas US Holding, Inc., has agreed to acquire 100% of the outstanding shares of Iveric Bio for US$40.00 per share in cash for a total equity value of approximately US$5.9 billion.
April 30, 2023
·
21 min read
Layoffs
IN8bio to Lay Off About 49% of Employees
Facing financial challenges, IN8bio is looking to preserve cash resources through a pipeline prioritization and layoffs at its New York City and Birmingham, Alabama, sites.
September 5, 2024
·
1 min read
·
Angela Gabriel
Pharm Country
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - July 05, 2023
IVERIC bio, Inc. reported that on July 3, 2023, the Company granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to 23 newly-hired, non-executive employees.
July 5, 2023
·
1 min read
Pharm Country
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 02, 2023
IVERIC bio, Inc. reported that on May 19, 2023, the Company granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to three newly-hired, non-executive employees.
June 2, 2023
·
1 min read
Pharm Country
Iveric Bio to Present at Upcoming November 2022 Investor Conferences
IVERIC bio, Inc. announced that Iveric Bio management will participate in fireside chats at the following investor conferences in November.
November 4, 2022
·
2 min read
Pharm Country
Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 24, 2023
IVERIC bio, Inc. reported that on May 19, 2023, the Company granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to 63 newly-hired, non-executive employees.
May 24, 2023
·
2 min read
Deals
Astellas to Buy Iveric Bio for $5.9B in Age-Related Blindness Play
Japanese biopharma scoops up Iveric’s investigational drug for age-related blindness disease. The drug, which trails Apellis’ Syfovre, is awaiting FDA approval with a decision expected by August.
May 1, 2023
·
2 min read
·
Kate Goodwin
BioMidwest
Aruna Bio to Present at BIO International Convention 2024
Aruna Bio, Inc. announced that Stephen From, Chief Executive Officer of Aruna Bio, will be presenting a corporate overview at the 2024 BIO International Convention being held June 3-6, 2024 at the San Diego Convention Center, California.
May 28, 2024
·
1 min read
Business
Iveric Bio Announces the Addition of Pravin U. Dugel, MD, to its Board of Directors
IVERIC bio, Inc. (Nasdaq: ISEE) announced today the election of Pravin U. Dugel, MD, President of Iveric Bio, to its Board of Directors, effective as of January 1, 2023.
January 3, 2023
·
8 min read
1 of 82,285
Next